Anthony G. Tebbutt
Präsident bei UCB Pharma, Inc.
Profil
Anthony G.
Tebbutt currently works at UCB Pharma, Inc., as President.
Mr. Tebbutt also formerly worked at Azur Pharma Ltd., as Director, Alexza Pharmaceuticals, Inc., as SVP-Corporate Strategy & Business Development from 2007 to 2009, UCB SA, as President from 1996 to 2006, Eli Lilly Canada, Inc., as Marketing Manager from 1974 to 1983, and Syntex Laboratories, Inc., as VP-New Product Planning & Marketing from 1983 to 1995.
Mr. Tebbutt received his Masters Business Admin degree from Stanford University and undergraduate degree from Santa Clara University.
Aktive Positionen von Anthony G. Tebbutt
| Unternehmen | Position | Beginn |
|---|---|---|
UCB Pharma, Inc.
 UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Präsident | - |
Ehemalige bekannte Positionen von Anthony G. Tebbutt
| Unternehmen | Position | Ende |
|---|---|---|
Azur Pharma Ltd.
 Azur Pharma Ltd. Pharmaceuticals: MajorHealth Technology Azur Pharma Ltd. manufactures pharmaceutical products. It offers branded generic prescription drugs, antibiotics and medicines in multiple therapeutic areas. The company was founded in May, 2005 and is headquartered in Dublin, IE | Direktor/Vorstandsmitglied | 18.01.2012 |
| ALEXZA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31.05.2009 |
| UCB | Präsident | 01.10.2006 |
| Syntex Laboratories, Inc. | Vertrieb & Marketing | 01.01.1995 |
Eli Lilly Canada, Inc.
 Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Canada, Inc. is a healthcare leader that focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. The company is based in Scarborough, Canada. Established in 1938, the Canadian company collaborates with scientists to produce innovative medicines that make life better for people around the world. The company's mission is to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to communities through philanthropy and volunteerism. | Vertrieb & Marketing | 01.01.1983 |
Ausbildung von Anthony G. Tebbutt
| Stanford University | Masters Business Admin |
| Santa Clara University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| UCB | Health Technology |
| Private Unternehmen | 5 |
|---|---|
UCB Pharma, Inc.
UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Commercial Services |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA. | Health Technology |
| Syntex Laboratories, Inc. | |
Eli Lilly Canada, Inc.
Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Canada, Inc. is a healthcare leader that focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. The company is based in Scarborough, Canada. Established in 1938, the Canadian company collaborates with scientists to produce innovative medicines that make life better for people around the world. The company's mission is to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to communities through philanthropy and volunteerism. | Health Technology |
Azur Pharma Ltd.
Azur Pharma Ltd. Pharmaceuticals: MajorHealth Technology Azur Pharma Ltd. manufactures pharmaceutical products. It offers branded generic prescription drugs, antibiotics and medicines in multiple therapeutic areas. The company was founded in May, 2005 and is headquartered in Dublin, IE | Health Technology |